Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disease involving the mouth.
Biomarker and diagnostic research for mouth disorder has been reported in the published literature.
24 clinical trials registered, 7 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE4, 3 PHASE3, 1 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06699433](https://clinicaltrials.gov/study/NCT06699433) |
Data assembled from 3 of 12 sources · Last updated Nov 3, 2026, 8:25 AM UTC
Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial |
NA |
Southern Medical University, China |
RECRUITING |
[NCT06882564](https://clinicaltrials.gov/study/NCT06882564) | Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis. | PHASE3 | Al-Mustansiriyah University | RECRUITING |
[NCT06900881](https://clinicaltrials.gov/study/NCT06900881) | Role of Kefir Mouth Wash in Oral Health Status Amelioration | PHASE2 | Al-Mustansiriyah University | RECRUITING |
[NCT06263439](https://clinicaltrials.gov/study/NCT06263439) | Surveillance of HFMD in Pediatric Outpatients | — | University Hospital, Clermont-Ferrand | RECRUITING |
[NCT06734832](https://clinicaltrials.gov/study/NCT06734832) | Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) | PHASE3 | Sinovac Biotech Co., Ltd | RECRUITING |
164 publications have been identified in PubMed for mouth disorder. Research spans Review / Meta-Analysis (45%), Basic Science / Preclinical (15%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 74 | 45% |
Laboratory research | 24 | 15% |
Disease patterns and progression | 23 | 14% |
Clinical study results | 14 | 9% |
Patient case studies | 11 | 7% |
Testing and diagnosis research | 9 | 5% |
New treatment approaches | 5 | 3% |
Other research | 4 | 2% |
Wu Y (2026). [PMID: 40587916](https://pubmed.ncbi.nlm.nih.gov/40587916/). *Biomaterials*. [Basic Science / Preclinical]
Munkhsaikhan U (2026). [PMID: 41516397](https://pubmed.ncbi.nlm.nih.gov/41516397/). *Int J Mol Sci*. [Review / Meta-Analysis]
Tavasoli A (2026). [PMID: 41225103](https://pubmed.ncbi.nlm.nih.gov/41225103/). *Advances in experimental medicine and biology*. [Basic Science / Preclinical]
Burch K (2026). [PMID: 42019703](https://pubmed.ncbi.nlm.nih.gov/42019703/). *Neurosci Biobehav Rev*. [Review / Meta-Analysis]
Qiu C (2026). [PMID: 41916092](https://pubmed.ncbi.nlm.nih.gov/41916092/). *Int Dent J*. [Review / Meta-Analysis]
Elkin L (2026). [PMID: 41648152](https://pubmed.ncbi.nlm.nih.gov/41648152/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Gallagher J (2026). [PMID: 41760757](https://pubmed.ncbi.nlm.nih.gov/41760757/). *British dental journal*. [Epidemiology / Natural History]
Warnakulasuriya S (2026). [PMID: 41254953](https://pubmed.ncbi.nlm.nih.gov/41254953/). *Journal of dental research*. [Gene Therapy / Novel Therapeutics]
Khemis A (2026). [PMID: 41109679](https://pubmed.ncbi.nlm.nih.gov/41109679/). *J Stomatol Oral Maxillofac Surg*. [Review / Meta-Analysis]
Lin J (2026). [PMID: 41123107](https://pubmed.ncbi.nlm.nih.gov/41123107/). *Oral Dis*. [Review / Meta-Analysis]